Sneaky deals are keeping cheaper generic medicines off the market

Los Angeles Times

This post has been archived and contains information that may be out of date.

It’s bad enough drug companies charge sky-high prices for brand-name prescription meds and raise those prices with regular frequency. Some also cut secret deals to keep cheaper generic alternatives off the market — a practice known as pay for delay.

It’s a bad-faith ploy that affects millions of people, potentially endangering the lives of patients who can’t afford needed medicine.

And it could become illegal in California.

A bill — AB 824 — now making its way through the Legislature would prohibit agreements among drug companies involving “anything of value” changing hands to delay introduction of a generic alternative to a brand-name medicine.